PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease

NCT00343954 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Angiogenix